Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation

Cantharidin skin blisters were examined over two days to model the acute and resolving phases of inflammation in human skin. Four blisters were created by topical administration of cantharidin (0.1% v/v) to the forearm of healthy volunteers, with IRB approval. Duplicate skin blisters were aspirated...

Full description

Saved in:
Bibliographic Details
Main Authors: Betsy J. Evans, Dorian O. Haskard, Gregory Sempowksi, R. Clive Landis
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/780502
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562410175594496
author Betsy J. Evans
Dorian O. Haskard
Gregory Sempowksi
R. Clive Landis
author_facet Betsy J. Evans
Dorian O. Haskard
Gregory Sempowksi
R. Clive Landis
author_sort Betsy J. Evans
collection DOAJ
description Cantharidin skin blisters were examined over two days to model the acute and resolving phases of inflammation in human skin. Four blisters were created by topical administration of cantharidin (0.1% v/v) to the forearm of healthy volunteers, with IRB approval. Duplicate skin blisters were aspirated at 16 and 40 hours to model the proinflammatory and resolving phases, respectively. There was a significant increase in leukocyte infiltrate at 40 h with appearance of a “resolving macrophage” phenotype CD14+CD163+ by flow cytometry. Neutrophils acquired apoptotic markers at 40 h and were observed to be phagocytosed by macrophagic “Reiter’s” cells. Multiplex cytokine analysis demonstrated that monocyte chemoattractant protein (MCP-1/CCL2), interleukin- (IL-) 6, IL-8/CXCL8, macrophage inflammatory protein (MIP1α/CCL3), MIP-1β/CCL4, tumor necrosis factor- (TNF-) α, and eotaxin (CCL11) were all significantly upregulated at 16 h compared with 40 h. In contrast, immunoregulatory transforming growth factor- (TGF-) β, macrophage-derived chemokine (MDC/CCL22), and interferon-inducible protein (IP-10/CXCL10) were significantly elevated at 40 h. Our results demonstrate that the phases of inflammation and resolution can be discriminated in a two-day model of dermal wound healing. This confirms and extends our understanding of wound repair in humans and provides a powerful research tool for use in clinical settings and to track the molecular benefits of therapeutic intervention.
format Article
id doaj-art-6de25ccef6b14338b4612e216088e29b
institution Kabale University
issn 2090-8040
2042-0099
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-6de25ccef6b14338b4612e216088e29b2025-02-03T01:22:47ZengWileyInternational Journal of Inflammation2090-80402042-00992013-01-01201310.1155/2013/780502780502Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving InflammationBetsy J. Evans0Dorian O. Haskard1Gregory Sempowksi2R. Clive Landis3Eric Bywaters Centre for Vascular Inflammation, Faculty of Medicine, Imperial College London, London W12 0NN, UKEric Bywaters Centre for Vascular Inflammation, Faculty of Medicine, Imperial College London, London W12 0NN, UKDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USAChronic Disease Research Centre, The University of the West Indies, Bridgetown 11115, BarbadosCantharidin skin blisters were examined over two days to model the acute and resolving phases of inflammation in human skin. Four blisters were created by topical administration of cantharidin (0.1% v/v) to the forearm of healthy volunteers, with IRB approval. Duplicate skin blisters were aspirated at 16 and 40 hours to model the proinflammatory and resolving phases, respectively. There was a significant increase in leukocyte infiltrate at 40 h with appearance of a “resolving macrophage” phenotype CD14+CD163+ by flow cytometry. Neutrophils acquired apoptotic markers at 40 h and were observed to be phagocytosed by macrophagic “Reiter’s” cells. Multiplex cytokine analysis demonstrated that monocyte chemoattractant protein (MCP-1/CCL2), interleukin- (IL-) 6, IL-8/CXCL8, macrophage inflammatory protein (MIP1α/CCL3), MIP-1β/CCL4, tumor necrosis factor- (TNF-) α, and eotaxin (CCL11) were all significantly upregulated at 16 h compared with 40 h. In contrast, immunoregulatory transforming growth factor- (TGF-) β, macrophage-derived chemokine (MDC/CCL22), and interferon-inducible protein (IP-10/CXCL10) were significantly elevated at 40 h. Our results demonstrate that the phases of inflammation and resolution can be discriminated in a two-day model of dermal wound healing. This confirms and extends our understanding of wound repair in humans and provides a powerful research tool for use in clinical settings and to track the molecular benefits of therapeutic intervention.http://dx.doi.org/10.1155/2013/780502
spellingShingle Betsy J. Evans
Dorian O. Haskard
Gregory Sempowksi
R. Clive Landis
Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
International Journal of Inflammation
title Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
title_full Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
title_fullStr Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
title_full_unstemmed Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
title_short Evolution of the Macrophage CD163 Phenotype and Cytokine Profiles in a Human Model of Resolving Inflammation
title_sort evolution of the macrophage cd163 phenotype and cytokine profiles in a human model of resolving inflammation
url http://dx.doi.org/10.1155/2013/780502
work_keys_str_mv AT betsyjevans evolutionofthemacrophagecd163phenotypeandcytokineprofilesinahumanmodelofresolvinginflammation
AT dorianohaskard evolutionofthemacrophagecd163phenotypeandcytokineprofilesinahumanmodelofresolvinginflammation
AT gregorysempowksi evolutionofthemacrophagecd163phenotypeandcytokineprofilesinahumanmodelofresolvinginflammation
AT rclivelandis evolutionofthemacrophagecd163phenotypeandcytokineprofilesinahumanmodelofresolvinginflammation